APA (7th ed.) Citation

FT, G., FL, C., S, B., S, B., P, V., L, L., & F, C. (2025). BRAF mutation and neoadjuvant chemo-immunotherapy, is it worthwhile? Lung cancer (Amsterdam, Netherlands), 203, 108514. https://doi.org/10.1016/j.lungcan.2025.108514

Chicago Style (17th ed.) Citation

FT, Gallina, Cecere FL, Bergomi S, Buglioni S, Visca P, Landi L, and Cappuzzo F. "BRAF Mutation and Neoadjuvant Chemo-immunotherapy, Is It Worthwhile?" Lung Cancer (Amsterdam, Netherlands) 203 (2025): 108514. https://doi.org/10.1016/j.lungcan.2025.108514.

MLA (9th ed.) Citation

FT, Gallina, et al. "BRAF Mutation and Neoadjuvant Chemo-immunotherapy, Is It Worthwhile?" Lung Cancer (Amsterdam, Netherlands), vol. 203, 2025, p. 108514, https://doi.org/10.1016/j.lungcan.2025.108514.